Medscape Medical News, July 05, 2024 Early LAIs for Schizophrenia Lower Hospital Readmission Risk Early in-hospital administration of long-acting injectable antipsychotics for schizophrenia is ...

Standards of care for schizophrenia treatment already call for long-acting injections over daily oral medication but still list pills ... of Long-Acting Injectable Antipsychotics Versus Oral ...

Antipsychotic drugs can be a big help in managing your schizophrenia symptoms. But they can have side effects. Your doctor should talk with you about their benefits and risks. Antipsychotic ...

and a team of pharmacists piloted an innovative program to overcome gaps in adherence to long-acting injectable antipsychotics (LAIs) in individuals with schizophrenia. 1 Though the pilot study ...

The FDA approved a new monthly paliperidone palmitate (Erzofri) extended-release injectable suspension for treating schizophrenia in adults, Luye Pharma announced. An atypical antipsychotic ...

Nuechterlein said the next stage of the research will be examining whether there are additional benefits of a long-acting injectable antipsychotic medication, and if it is just as effective if ...

“The primary objective of this study was to assess the prescribing patterns of long acting injectable (LAI) antipsychotics in an older adult population. Secondary objectives were to determine if ...